Xcout Intel
Acarix
Acarix is a Swedish medical technology company that develops diagnostic tools for detecting coronary artery disease. Its CADScor System uses cardiac sound analysis to help clinicians assess patients with suspected coronary artery disease and determine whether further testing may be needed.
Subscribe to see Acarix’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Acarix competitors
A few of Acarix's closest competitors — see the full list of competitors and alternatives →
Genetesis LLC is a U.S. medical-technology company developing noninvasive cardiac-imaging and diagnostic tools based on biomagnetic sensing. Its technology is intended for healthcare providers and researchers evaluating cardiovascular conditions, including ischemic heart disease.
Sensydia Corp is a medical devices and equipment company established in 2015 and based in Los Angeles, California. The company develops diagnostic technologies and non-invasive cardiac monitoring systems.
Caristo Diagnostics is a medical equipment manufacturing company headquartered in Oxford, United Kingdom. It specializes in developing medical devices for the diagnosis of vascular disease, operating with international presence including an office in Stamford, USA.
Perimed is a medical technology company founded in 1981 and headquartered near Stockholm, Sweden, specializing in the development and manufacturing of innovative vascular diagnostic instruments.
SciBase Holding AB is a Swedish medical-technology company whose primary product, Nevisense, uses electrical impedance spectroscopy to support the assessment of suspicious skin lesions, including melanoma. It serves dermatologists and other healthcare professionals involved in skin-cancer detection and diagnosis.
Aerocrine AB was a Swedish medical technology company that developed and commercialized NIOX systems for measuring exhaled nitric oxide (FeNO). Its products were used by healthcare professionals to support the diagnosis and management of asthma and airway inflammation; the company was acquired by Circassia Pharmaceuticals in 2015.
Get Acarix's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Acarix in Xcout Intel
- The full competitor set, tracking, exports and API access